Angiotensin Receptor Blockers : Current Status and Future ProspectsRAM, C. Venkata S.The American journal of medicine. 2008, Vol 121, Num 8, pp 656-663, issn 0002-9343, 8 p.Article

Angiotensin II-receptor blocker dosages : How high should we go?DÜSING, R.International journal of clinical practice (Esher). 2006, Vol 60, Num 2, pp 179-183, issn 1368-5031, 5 p.Article

Increased Capillary Branching Contributes to Angiotensin Type 1 Receptor Blocker (ARB)―Induced Regression of SclerosisSCRUGGS, Benjamin S; YIQIN ZUO; DONNERT, Ellen et al.The American journal of pathology. 2011, Vol 178, Num 4, pp 1891-1898, issn 0002-9440, 8 p.Article

Feasibility of treating prehypertension with an angiotensin-receptor blockerJULIUS, Stevo; NESBITT, Shawna D; SCHORK, M. Anthony et al.The New England journal of medicine. 2006, Vol 354, Num 16, pp 1685-1697, issn 0028-4793, 13 p.Article

Angiotensin receptor antagonists : a new class of antihypertensive drugGIBBS, C. R; FERNER, R. E; BEEVERS, D. G et al.Journal of clinical pharmacy and therapeutics (Print). 1996, Vol 21, Num 3, pp 127-130, issn 0269-4727Article

Twisting arms to angiotensin receptor blockers/antagonists: the turn of cancerVOLPE, Massimo; AZIZI, Michel; JAN DANSER, A. H et al.European heart journal. 2011, Vol 32, Num 1, pp 19-22, issn 0195-668X, 4 p.Article

Angiotensin II can induce and potentiate shape change in human platelets : effect of losartanJAGROOP, I. A; MIKHAILIDIS, D. P.Journal of human hypertension. 2000, Vol 14, Num 9, pp 581-585, issn 0950-9240Article

Uptake of angiotensin II receptor blockers in the treatment of hypertensionGREVING, Jacoba P; DENIG, Petra; VAN DER VEEN, Willem Jan et al.European journal of clinical pharmacology. 2005, Vol 61, Num 5-6, pp 461-466, issn 0031-6970, 6 p.Article

High-Affinity Interaction of Sartans with H⁺/Peptide TransportersKNÜTTER, Ilka; KOTTRA, Gabor; FISCHER, Wiebke et al.Drug metabolism and disposition. 2009, Vol 37, Num 1, pp 143-149, issn 0090-9556, 7 p.Article

2nd international forum on angiotensin II receptor antagonism (Monte-Carlo, January 24-26 2001, abstracts)International forum on angiotensin II receptor antagonism. 2001, 44 p.Conference Proceedings

Angiotensin receptor antagonists and increased risk of cancer. Further evidence againstMANCIA, Giuseppe.Journal of hypertension. 2011, Vol 29, Num 4, pp 653-654, issn 0263-6352, 2 p.Article

Rationale and design of a trial on the effect of angiotensin II receptor blockers on the function of the systemic right ventricleVAN DER BOM, Teun; WINTER, Michiel M; MULDER, Barbara J. M et al.The American heart journal. 2010, Vol 160, Num 5, pp 812-818, issn 0002-8703, 7 p.Article

A hard look at angiotensin receptor blockers in heart failureGRING, Christian N; FRANCIS, Gary S.Journal of the American College of Cardiology. 2004, Vol 44, Num 9, pp 1841-1846, issn 0735-1097, 6 p.Article

Structural characterization of three crystalline modifications of telmisartan by single crystal and high-resolution X-ray powder diffractionDINNEBIER, Robert E; SIEGER, Peter; NAR, Herbert et al.Journal of pharmaceutical sciences. 2000, Vol 89, Num 11, pp 1465-1479, issn 0022-3549Article

Understanding the implications for angiotensin II receptor blockade in the long-term management of hypertensionGRADMAN, Alan H.The American journal of cardiology. 1999, Vol 84, Num 10A, issn 0002-9149, 43 p.Serial Issue

Long-term follow-up of renal transplant recipients treated with losartan for post-transplant erythrosisDUCLOUX, D; FOURNIER, V; BRESSON-VAUTRIN, C et al.Transplant international. 1998, Vol 11, Num 4, pp 312-315, issn 0934-0874Article

Discovery of new angiotensin II receptor antagonists. A review of pharmacological studiesMERLOS, M; RABASSEDA, X; SILVESTRE, J. S et al.Methods and findings in experimental and clinical pharmacology. 1998, Vol 20, Num 9, pp 805-815, issn 0379-0355Article

A conformationally restrained series of AT₁-selective angiotensin II antagonistsCARPINO, P. A; SNEDDON, S. F; DE SILVA JARDINE, P et al.Bioorganic & medicinal chemistry letters (Print). 1994, Vol 4, Num 1, pp 93-98, issn 0960-894XArticle

Effects of D-amino acid substitution on antagonist activities of angiotensin II analoguesSAMANEN, J; NARINDRAY, D; ADAMS, W. JR et al.Journal of medicinal chemistry (Print). 1988, Vol 31, Num 3, pp 510-516, issn 0022-2623Article

Vaisseaux, cœur et rein: l'angiotensine II toujours d'actualité: Agir avant l'accident: impact des antagonistes de l'angiotensine IIBONNET, J; OBREJA, D.Archives des maladies du coeur et des vaisseaux. Pratique. 2011, Num MARS, issn 1261-694X, S1-S3, SUP1Article

Angiotensin II receptor blockers for the treatment of heart failure : A class effect?HUDSON, Marie; HUMPHRIES, Karin; TU, Jack V et al.Pharmacotherapy. 2007, Vol 27, Num 4, pp 526-534, issn 0277-0008, 9 p.Article

Effect of losorlan on muscle sympathetic activity and baroreceptor function in systemic hypertensionBECHIR, Markus; ENSELEIT, Frank; CHENEVARD, Rémy et al.The American journal of cardiology. 2005, Vol 95, Num 1, pp 129-131, issn 0002-9149, 3 p.Article

Angiotensin II receptor antagonists: Role in hypertension, cardiovascular disease, and renoprotectionAPPEL, Gerald B; APPEL, Alice S.Progress in cardiovascular diseases. 2004, Vol 47, Num 2, pp 105-115, issn 0033-0620, 11 p.Article

les antagonistes des récepteurs de l'angiotensine II: différents ou équivalents? = Angiotensin II receptor antagonists: are they all the same ?MOUNIER-VEHIER, C; DEVOS, P.La Presse médicale (1983). 2001, Vol 30, Num 21, pp 1072-1075, issn 0755-4982Article

New Clinical Trials of Angiotensin Blockade in Cardiovascular DiseaseJULIUS, Stevo.American journal of hypertension. 2000, Vol 13, Num 5, issn 0895-7061, 30 p., 2Serial Issue